Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 50
Gene Symbol: ACO2
ACO2
0.010 Biomarker disease BEFREE Although the level of N-AcO-2-FAA that bound to mononuclear leukocyte DNA was the same for the various population groups, the level of N-AcO-2-FAA-induced unscheduled DNA synthesis (UDS) was significantly reduced in the mononuclear leukocytes of individuals who had had colorectal cancer or a genetic predisposition for the disease. 6573531 1983
Entrez Id: 2175
Gene Symbol: FANCA
FANCA
0.010 Biomarker disease BEFREE Although the level of N-AcO-2-FAA that bound to mononuclear leukocyte DNA was the same for the various population groups, the level of N-AcO-2-FAA-induced unscheduled DNA synthesis (UDS) was significantly reduced in the mononuclear leukocytes of individuals who had had colorectal cancer or a genetic predisposition for the disease. 6573531 1983
Entrez Id: 2184
Gene Symbol: FAH
FAH
0.010 Biomarker disease BEFREE Although the level of N-AcO-2-FAA that bound to mononuclear leukocyte DNA was the same for the various population groups, the level of N-AcO-2-FAA-induced unscheduled DNA synthesis (UDS) was significantly reduced in the mononuclear leukocytes of individuals who had had colorectal cancer or a genetic predisposition for the disease. 6573531 1983
Entrez Id: 5670
Gene Symbol: PSG2
PSG2
0.100 GeneticVariation disease BEFREE Comparison of two CEA assays in primary and recurrent large bowel carcinoma with different DNA ploidy pattern. 3816909 1986
Entrez Id: 1087
Gene Symbol: CEACAM7
CEACAM7
0.100 GeneticVariation disease BEFREE Comparison of two CEA assays in primary and recurrent large bowel carcinoma with different DNA ploidy pattern. 3816909 1986
Entrez Id: 1084
Gene Symbol: CEACAM3
CEACAM3
0.100 GeneticVariation disease BEFREE Comparison of two CEA assays in primary and recurrent large bowel carcinoma with different DNA ploidy pattern. 3816909 1986
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.100 GeneticVariation disease BEFREE Comparison of two CEA assays in primary and recurrent large bowel carcinoma with different DNA ploidy pattern. 3816909 1986
Entrez Id: 2191
Gene Symbol: FAP
FAP
0.100 GeneticVariation disease BEFREE This parallels the assignment of the FAP gene to chromosome 5 (see accompanying paper) and suggests that becoming recessive for this gene may be a critical step in the progression of a relatively high proportion of colorectal cancers. 2886919 1987
Entrez Id: 1084
Gene Symbol: CEACAM3
CEACAM3
0.100 Biomarker disease BEFREE Plasma CEA in large bowel carcinoma: which patients should be followed by regular postoperative measurements? Preliminary follow-up results in 100 patients with different tumor DNA-ploidy patterns. 3568033 1987
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.100 Biomarker disease BEFREE Plasma CEA in large bowel carcinoma: which patients should be followed by regular postoperative measurements? Preliminary follow-up results in 100 patients with different tumor DNA-ploidy patterns. 3568033 1987
Entrez Id: 1087
Gene Symbol: CEACAM7
CEACAM7
0.100 Biomarker disease BEFREE Plasma CEA in large bowel carcinoma: which patients should be followed by regular postoperative measurements? Preliminary follow-up results in 100 patients with different tumor DNA-ploidy patterns. 3568033 1987
Entrez Id: 5670
Gene Symbol: PSG2
PSG2
0.100 Biomarker disease BEFREE Plasma CEA in large bowel carcinoma: which patients should be followed by regular postoperative measurements? Preliminary follow-up results in 100 patients with different tumor DNA-ploidy patterns. 3568033 1987
Entrez Id: 2956
Gene Symbol: MSH6
MSH6
0.600 Biomarker disease BEFREE Increasing recognition of the statistical burden posed by HNPCC (5 to 6 percent of all colorectal cancer) mandates that physicians have a better understanding of the genetics, natural history, and distinction between the hereditary site-specific variant (Lynch syndrome I) and the Cancer Family Syndrome (Lynch syndrome II). 3366037 1988
Entrez Id: 3265
Gene Symbol: HRAS
HRAS
0.100 GeneticVariation disease BEFREE Ha-ras restriction fragment length polymorphisms in colorectal cancer. 2896015 1988
Entrez Id: 2249
Gene Symbol: FGF4
FGF4
0.030 GeneticVariation disease BEFREE However, no amplification of the hst-1 gene was detected in gastric and colorectal carcinomas. 3136110 1988
Entrez Id: 2908
Gene Symbol: NR3C1
NR3C1
0.030 GeneticVariation disease BEFREE Chromosome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas. 3342039 1988
Entrez Id: 6822
Gene Symbol: SULT2A1
SULT2A1
0.010 GeneticVariation disease BEFREE The hst-1 gene, previously designated as the hst gene, and seven other oncogenes were examined for possible structural changes in esophageal, gastric and colorectal carcinomas by Southern blot hybridization. 3136110 1988
Entrez Id: 3347
Gene Symbol: HTN3
HTN3
0.010 GeneticVariation disease BEFREE The hst-1 gene, previously designated as the hst gene, and seven other oncogenes were examined for possible structural changes in esophageal, gastric and colorectal carcinomas by Southern blot hybridization. 3136110 1988
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.700 GeneticVariation disease BEFREE Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. 2649981 1989
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.400 Biomarker disease BEFREE Thus we present evidence that in colorectal cancer only a small proportion of tumor-infiltrating macrophages produces TNF, indicating that the microenvironment of the tumor provides adequate, yet suboptimal, conditions for macrophage activation. 2662193 1989
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B
0.140 AlteredExpression disease BEFREE The results show that a considerable proportion of colorectal carcinomas is heterogeneous with regard to HLA-A and HLA-B expression. 2462591 1989
Entrez Id: 3105
Gene Symbol: HLA-A
HLA-A
0.100 AlteredExpression disease BEFREE The results show that a considerable proportion of colorectal carcinomas is heterogeneous with regard to HLA-A and HLA-B expression. 2462591 1989
Entrez Id: 2249
Gene Symbol: FGF4
FGF4
0.030 GeneticVariation disease BEFREE No coamplification of the hst-1 and int-2 genes was detected in gastric carcinomas and colorectal carcinomas. 2529025 1989
Entrez Id: 4803
Gene Symbol: NGF
NGF
0.020 Biomarker disease BEFREE The molecular mechanism by which NGF and PDGF affect growth of tumor cells was tested in human melanoma WM 266-4 and colorectal carcinoma SW 707 cell lines. 2775292 1989
Entrez Id: 57508
Gene Symbol: INTS2
INTS2
0.010 GeneticVariation disease BEFREE No coamplification of the hst-1 and int-2 genes was detected in gastric carcinomas and colorectal carcinomas. 2529025 1989